AMI Acute myocardial infarction ANG Coronary angioplasty/stenting ASCI Ascites AVN Avascular necrosis in the femural head BYP Coronary artery by-pass grafting CERC Cervical cerclage CLD Chronic liver disease COR (Possible) Coronary Death DIA Diabetes mellitus END Carotic endarterectomy ESRD End stage renal disease FAT Fatal case with insufficient data FIBS Fibroscan FRA Bone fracture (irrespective of location) HEP Severe hepatic encephalopathy (stage III or IV) HESY Hepatorenal syndrome ICP Invasive Cardiovascular Procedures LAC Lactic acidosis LIVB Liver biopsy NADM Non-AIDS defining malignancies OESO Oesophageal variceal bleeding PAN Pancreatitis PERI Spontaneous bacterial peritonitis STR Stroke (infarction or haemorrhagia) ANEM Anemia (<10g/l) FEV Fever (> 38 0C and > 1 day) URITINF Urinary tract infection HEMATOMA Hematoma ENDOM Endometritis WOUINF Wound infection PERIT Peritonitis PNEU Pneumonia SEPSIS Sepsis (fever and pos blood culture) THROMB Thromboembolism DIC Disseminated intravascular coagulation (DIC) SUBI Subileus/ ileus HEMOR Hemorrhage PSY Psychosis PREECL Preeclampsia/eclampsia ANEMBL Severe anemia requiring blood transfusion SEIZ Seizures ONEU Other neurological symptoms (use with AE_DESCRIP) OABN Other abnormal findings (use with AE_DESCRIP) AMI DAMI AMI PAMI ICP ANG ICP BYP ICP END NADM ALL NADM AML NADM ANUS NADM BLAD NADM BRCA NADM CERV NADM CLL NADM CML NADM COLO NADM COTC NADM HDL NADM KIDN NADM LEUK NADM LIPC NADM LIVR NADM LUNG NADM MALM NADM MEAC NADM MEOC NADM MESC NADM META NADM MULM NADM PENC NADM PROS NADM RECT NADM STOM NADM TESE NADM UTER STR SHAE STR SINF STR SUNK J05A ART unspecified J05A-BEV Beviramat J05A-PBT Participant in Blinded Trial J05AE PI unspecified J05AE-MOZ Mozenavir (DMP-450) J05AE01 Saquinavir (gel, not specified) J05AE01-SQH Saquinavir hard gel (INVIRASE) J05AE01-SQS Saquinavir soft gel (FORTOVASE) J05AE02 Indinavir (CRIXIVAN) J05AE03 Ritonavir (NORVIR) J05AE03-H Ritonavir high dose (NORVIR) J05AE03-L Ritonavir low dose (NORVIR) J05AE04 Nelfinavir (VIRACEPT) J05AE05 Amprenavir (AGENERASE) J05AE06 Lopinavir/Ritonavir (Kaletra) J05AE07 Fos-amprenavir (Telzir, Lexiva) J05AE08 Atazanavir (Reyataz) J05AE09 Tipranavir (Aptivus) J05AE10 Darunavir (TMC-114, Prezista) J05AF NRTI unspecified J05AF-ALO Alovudine J05AF-AMD Amdoxovir (DADP) J05AF-FOZ Fozivudine tidoxi J05AF-LDN Lodenosine (trialdrug) J05AF-RVT Reverset J05AF01 Zidovudine (AZT, RETROVIR) J05AF02 Didanosine (ddI) (VIDEX) J05AF03 Zalcitabine (ddC) (HIVID) J05AF04 Stavudine (d4T) (ZERIT) J05AF05 Lamivudine (3TC, EPIVIR) J05AF06 Abacavir (1592U89) (ZIAGEN) J05AF07 Tenofovir (VIREAD) J05AF08 Adefovir (PREVEON) J05AF09 Emtricitabine J05AF10 Entecavir J05AF11 Telbivudine J05AG NNRTI unspecified J05AG04 Etravirine (TMC 125) J05AG05 Rilpivirine (TMC-278) J05AG-CPV Capravirine J05AG-DPC083 DPC 083 J05AG-DPC961 DPC 961 J05AG-EMV Emivirine (MKC442) J05AG-LOV Loviride J05AG01 Nevirapine (VIRAMUN) J05AG02 Delavirdine (U-90152) (RESCRIPTOR) J05AG03 Efavirenz (DMP-266) (STOCRIN, SUSTIVA) J05AR01 Combivir (Zidovudine/Lamivudine) J05AR02 Kivexa (Lamivudine/Abacavir) J05AR03 Truvada (Tenofovir/Emtricabine) J05AR04 Trizivir (Zidovudine/Lamivudine/Abacavir) J05AR05 Douvir-N (Zidovudine/Lamivudine/Nevirapine) J05AR06 Atripla (Emtricitabine/Tenofovir/Efavirenz) J05AX-EVG Elvitegravir (Gilead) J05AX-VIC Vicriviroc (Schering) J05AX07 Enfuvirtide (Fuzeon, T-20) J05AX08 Raltegravir (Merck) J05AX09 Maraviroc (Pfizer) L01XX05 Hydroxyurea/Hydroxycarbamid (Litalir) 1 Treatment failure (i.e. virological, immunological, and/or clinical failure 1.1 Virological failure 1.2 Partial virological failure 1.3 Immunological failure - CD4 drop 1.4 Clinical progression 2 Abnormal fat redistribution 3 Concern of cardiovascular disease 3.1 Dyslipidaemia 3.2 Cardiovascular disease 4 Hypersensitivity reaction 5 Toxicity, predominantly from abdomen/G-I tract 5.1 Toxicity - GI tract 5.2 Toxicity - Liver 5.3 Toxicity - Pancreas 6 Toxicity, predominantly from nervous system 7 Toxicity, predominantly from kidneys 8 Toxicity, predominantly from endocrine system 8.1 Diabetes 9 Haematological toxicity (anemia etc.) 10 Hyperlactataemie/lactic acidosis 88 Death 90 Side effects - any of the above but unspecified 90.1 Comorbidity 91 Toxicity, not mentioned above 92 Availability of more effective treatment (not specifically failure or side effect related) 92.1 Simplified treatment available 92.2 Treatment too complex 92.3 Drug interaction 93 Structured Treatment Interruption (STI) 93.1 Structured Treatment Interruption (STI) - at high CD4 94 Patient's wish/decision, not specified above 94.1 Non-compliance 95 Physician's decision, not specified above 96 Pregnancy 97 Study treatment 98 Other causes, not specified above 99 Unknown 10 White 20 Black 21 Black African 22 Black Caribbean 30 Hispanic 40 Asian 50 Americas 60 Indigenous 1020 1+2 1040 1+4 2030 2+3 3040 3+4 98 Prohibited 99 Unknown 1 homo/bisexual 2 injecting drug user 3 (1+2) 4 haemophiliac 5 transfusion, non-haemophilia related 6 heterosexual contact 7 (6+2) 8 Perinatal 90 other, (specify) 99 unknown 001 World 002 Africa 014 -Eastern Africa 017 -Middle Africa 015 -Northern Africa 018 -Southern Africa 011 -Western Africa 019 Americas 419 -Latin America and the Caribbean 029 --Caribbean 013 --Central America 005 --South America 021 -Northern America 142 Asia 143 -Central Asia 030 -Eastern Asia 034 -Southern Asia 035 -South-Eastern Asia 145 -Western Asia 150 Europe 151 -Eastern Europe 154 -Northern Europe 039 -Southern Europe 155 -Western Europe 009 Oceania 053 -Australia and New Zealand 054 -Melanesia 057 -Micronesia 061 -Polynesia 4 Afghanistan 248 \xc5land Islands 8 Albania 12 Algeria 16 American Samoa 20 Andorra 24 Angola 660 Anguilla 28 Antigua and Barbuda 32 Argentina 51 Armenia 533 Aruba 36 Australia 40 Austria 31 Azerbaijan 44 Bahamas 48 Bahrain 50 Bangladesh 52 Barbados 112 Belarus 56 Belgium 84 Belize 204 Benin 60 Bermuda 64 Bhutan 68 Bolivia (Plurinational State of) 535 Bonaire, Saint Eustatius and Saba 70 Bosnia and Herzegovina 72 Botswana 76 Brazil 92 British Virgin Islands 96 Brunei Darussalam 100 Bulgaria 854 Burkina Faso 108 Burundi 116 Cambodia 120 Cameroon 124 Canada 132 Cape Verde 136 Cayman Islands 140 Central African Republic 148 Chad 830 Channel Islands 152 Chile 156 China 344 China, Hong Kong Special Administrative Region 446 China, Macao Special Administrative Region 170 Colombia 174 Comoros 178 Congo 184 Cook Islands 188 Costa Rica 384 C\xf4te d'Ivoire 191 Croatia 192 Cuba 531 Cura\xe7ao 196 Cyprus 203 Czech Republic 408 Democratic People's Republic of Korea 180 Democratic Republic of the Congo 208 Denmark 262 Djibouti 212 Dominica 214 Dominican Republic 218 Ecuador 818 Egypt 222 El Salvador 226 Equatorial Guinea 232 Eritrea 233 Estonia 231 Ethiopia 234 Faeroe Islands 238 Falkland Islands (Malvinas) 242 Fiji 246 Finland 250 France 254 French Guiana 258 French Polynesia 266 Gabon 270 Gambia 268 Georgia 276 Germany 288 Ghana 292 Gibraltar 300 Greece 304 Greenland 308 Grenada 312 Guadeloupe 316 Guam 320 Guatemala 831 Guernsey 324 Guinea 624 Guinea-Bissau 328 Guyana 332 Haiti 336 Holy See 340 Honduras 348 Hungary 352 Iceland 356 India 360 Indonesia 364 Iran (Islamic Republic of) 368 Iraq 372 Ireland 833 Isle of Man 376 Israel 380 Italy 388 Jamaica 392 Japan 832 Jersey 400 Jordan 398 Kazakhstan 404 Kenya 296 Kiribati 414 Kuwait 417 Kyrgyzstan 418 Lao People's Democratic Republic 428 Latvia 422 Lebanon 426 Lesotho 430 Liberia 434 Libya 438 Liechtenstein 440 Lithuania 442 Luxembourg 450 Madagascar 454 Malawi 458 Malaysia 462 Maldives 466 Mali 470 Malta 584 Marshall Islands 474 Martinique 478 Mauritania 480 Mauritius 175 Mayotte 484 Mexico 583 Micronesia (Federated States of) 492 Monaco 496 Mongolia 499 Montenegro 500 Montserrat 504 Morocco 508 Mozambique 104 Myanmar 516 Namibia 520 Nauru 524 Nepal 528 Netherlands 540 New Caledonia 554 New Zealand 558 Nicaragua 562 Niger 566 Nigeria 570 Niue 574 Norfolk Island 580 Northern Mariana Islands 578 Norway 275 Occupied Palestinian Territory 512 Oman 586 Pakistan 585 Palau 591 Panama 598 Papua New Guinea 600 Paraguay 604 Peru 608 Philippines 612 Pitcairn 616 Poland 620 Portugal 630 Puerto Rico 634 Qatar 410 Republic of Korea 498 Republic of Moldova 638 R\xe9union 642 Romania 643 Russian Federation 646 Rwanda 652 Saint-Barth\xe9lemy 654 Saint Helena 659 Saint Kitts and Nevis 662 Saint Lucia 663 Saint-Martin (French part) 666 Saint Pierre and Miquelon 670 Saint Vincent and the Grenadines 882 Samoa 674 San Marino 678 Sao Tome and Principe 680 Sark 682 Saudi Arabia 686 Senegal 688 Serbia 690 Seychelles 694 Sierra Leone 702 Singapore 534 Sint Maarten (Dutch part) 703 Slovakia 705 Slovenia 90 Solomon Islands 706 Somalia 710 South Africa 728 South Sudan 724 Spain 144 Sri Lanka 729 Sudan 740 Suriname 744 Svalbard and Jan Mayen Islands 748 Swaziland 752 Sweden 756 Switzerland 760 Syrian Arab Republic 762 Tajikistan 764 Thailand 807 The former Yugoslav Republic of Macedonia 626 Timor-Leste 768 Togo 772 Tokelau 776 Tonga 780 Trinidad and Tobago 788 Tunisia 792 Turkey 795 Turkmenistan 796 Turks and Caicos Islands 798 Tuvalu 800 Uganda 804 Ukraine 784 United Arab Emirates 826 United Kingdom of Great Britain and Northern Ireland 834 United Republic of Tanzania 840 United States of America 850 United States Virgin Islands 858 Uruguay 860 Uzbekistan 548 Vanuatu 862 Venezuela (Bolivarian Republic of) 704 Viet Nam 876 Wallis and Futuna Islands 732 Western Sahara 887 Yemen 894 Zambia 716 Zimbabwe DEM AIDS dementia complex BCNE Bacterial pneumonia, recurrent (>2 episodes within 1 year) CANO Candidiasis, oesophageal, bronchi, trachea, or lungs COCC Coccidioidomycosis, disseminated or extrapulmonary CRCO Cryptococcosis, extrapulm. CRSP Cryptosporidiosis (duration > 1 month) CMVR Cytomegalovirus (CMV) chorioretinitis CMVO CMV \u2013 other location HERP Herpes simplex virus ulcers (duration > 1 month) or pneumonitis/esophagitis HIST Histoplasmosis, extrapulm. WAST HIV Wasting Syndrome ISDI Isosporiasis diarrhoea (duration > 1 month) LEIS Leishmaniasis, visceral MCDI Microsporidosis diarrhoes (dur. > 1 month) MC Mycobact. avium complex (MAC) or Kanasii, extrapulm. MCP Mycobact. tuberculosis pulm. MCX Mycobact. tuberculosis extrapulm MCPO Mycobact. pulm., other MCXO Mycobact. extrapulm., other PCP Pneumocystis carinii pneumonia (PCP) LEU Progressive multifocal leucoencephalopathy SAM Salmonella bacteriaemia (non-tyhpoid) (recurrent) TOX Toxoplasmosis, brain FBLS Focal Brain lesion KS Kaposi Sarcoma HG Hodgkins Lymphoma NHG Non-Hodgkin Lymphoma -not specified NHGB Non-Hodgkin Lymphoma \u2013 Burkitt (Classical or Atypical) NHGI Non-Hodgkin Lymphoma \u2013 Diffuse large B-cell lymphoma (Immunoblastic or Centroblastic) NHGU Non-Hodgkin Lymphoma - Unknown/other histology NHGP Non-Hodgkin Lymphoma - Primary Brain Lymphoma CRVC Cervical Cancer A CA-LYM A CA-HEY A CA-SPL A CA-DER A CA-PAR A CA-URI B CB-ANE B CB-BMP B CB-CAN B CB-CMY B CB-CMN B CB-DIA B CB-FEV B CB-HEP B CB-HSS B CB-HCV B CB-HZO B CB-LEI B CB-LYM B CB-NEP B CB-NOC B CB-TON B CB-VAR C CC-EPD C CC-TOD C CC-COM C CC-GEN C CC-LOB C CC-ICC C CC-ILE DEM AIDS dementia complex DEM AIDS dementia complex BCNE Bacterial pneumonia, recurrent (>2 episodes within 1 year) BCNE Bacterial pneumonia, recurrent (>2 episodes within 1 year) CANO Candidiasis, oesophageal, bronchi, trachea, or lungs CANO Candidiasis, oesophageal, bronchi, trachea, or lungs CRCO Cryptococcosis, extrapulm. CRSP Cryptosporidiosis (duration > 1 month) CMVR Cytomegalovirus (CMV) chorioretinitis CMVO CMV \u2013 other location HERP Herpes simplex virus ulcers (duration > 1 month) or pneumonitis/esophagitis HIST Histoplasmosis, extrapulm. WAST HIV Wasting Syndrome ISDI Isosporiasis diarrhoea (duration > 1 month) LEIS Leishmaniasis, visceral MCDI Microsporidosis diarrhoes (dur. > 1 month) MC Mycobact. avium complex (MAC) or Kanasii, extrapulm. MCP Mycobact. tuberculosis pulm. MCX Mycobact. tuberculosis extrapulm MCPO Mycobact. pulm., other MCPO Mycobact. pulm., other MCXO Mycobact. extrapulm., other MCXO Mycobact. extrapulm., other PCP Pneumocystis carinii pneumonia (PCP) PCP Pneumocystis carinii pneumonia (PCP) LEU Progressive multifocal leucoencephalopathy LEU Progressive multifocal leucoencephalopathy SAM Salmonella bacteriaemia (non-tyhpoid) (recurrent) TOX Toxoplasmosis, brain TOX Toxoplasmosis, brain FBLS Focal Brain lesion KS Kaposi Sarcoma KS Kaposi Sarcoma HG Hodgkins Lymphoma NHG Non-Hodgkin Lymphoma -not specified NHGB Non-Hodgkin Lymphoma \u2013 Burkitt (Classical or Atypical) NHGI Non-Hodgkin Lymphoma \u2013 Diffuse large B-cell lymphoma (Immunoblastic or Centroblastic) NHGU Non-Hodgkin Lymphoma - Unknown/other histology NHGP Non-Hodgkin Lymphoma - Primary Brain Lymphoma NHGP Non-Hodgkin Lymphoma - Primary Brain Lymphoma CRVC Cervical Cancer 1 Definitive diagnosis 2 Presumptive diagnosis 3 Diagnosis from autopsy 4 Diagnosis from registry ALB Albumine ALP Alk.P.tase ALT Alanin-Aminotransferase AMY Amylase APT Alk. Phosphatate AST Aspartat aminotransferase BIL Total Bilirubin CD3 CD3 CD3P % CD3 of leukocytes CD8 CD8 CD8P % CD8 of leukocytes CHOL Total Cholesterol CL- Cl- CRE Creatinine GGT Gamma-glutamyltransferase GLUC Glucose GLYCE Glycemia HAEM Haemoglobin HDL Serum HDL HEMA Hematocrit INR Quick/INR LACT Lactate LEUK Leukocytes LYM Lymphocytes LYMP % Lymphocytes of leukocytes MCV MCV NA+ Na+ NEU Neutrophils PHA PH arterial PHV PH venous PLT Platelet count PP PP factor (II, VII, X) PTR Prothrombin rate THR Thrombocytes TRIG Serum Triglyceride URA Uric acid WBC WBC count Alanin-Aminotransferase 5 Alanin-Aminotransferase 11 Albumine 2 Alk. Phosphatate 5 Amylase 5 Amylase 11 Creatinine 6 Gamma-glutamyltransferase 5 Glucose 1 Haemoglobin 1 Haemoglobin 2 Haemoglobin 3 Lactate 1 Lactate 4 Lymphocyte count 8 Lymphocyte count 9 Lymphocyte count 10 Platelet count 8 Platelet count 9 Platelet count 10 Prothrombin rate 12 Quick/INR 7 Serum HDL 1 Serum HDL 2 Serum HDL 3 Serum HDL 4 Serum HDL 5 Serum Triglyceride 1 Serum Triglyceride 2 Serum Triglyceride 4 Total Bilirubin 6 Total Cholesterol 1 Total Cholesterol 2 Total Cholesterol 3 Total Cholesterol 4 WBC count 8 WBC count 9 WBC count 10 1 mmHg 2 cmHg 3 Kpa A A1 A2 A3 B C D F F1 F2 G H J K CRF01_AE CM240 CRF02_AG IbNG CRF03_AB Kal153 CRF04_cpx 94CY032 CRF05_DF VI1310 CRF06_cpx BFP90 CRF07_BC 97CN54 CRF08_BC 97CNGX-6F CRF09_cpx 96GH2911 CRF10_CD TZBF061 CRF11_cpx GR17 CRF12_BF ARMA159 CRF13_cpx 96CM-1849 CRF14_BG X397 CRF15_01B 99TH.MU2079 CRF16_A2D 97KR004 CRF17_BF ARMA038 CRF18_cpx CU76 CRF19_cpx CU7 CRF20_BG Cu103 CRF21_A2D 99KE_KER2003 CRF22_01A1 CM001BBY CRF23_BG CB118 CRF24_BG CB378 CRF25_cpx 02CM_1918LE CRF26_AU 02CD_MBTB047 CRF27_cpx 04FR-KZS CRF28_BF BREPM12609 CRF29_BF BREPM16704 CRF30_0206 00NE36 CRF31_BC 04BR142 CRF32_06A1 EE0369 CRF33_01B 05MYKL007 CRF34_01B OUR2275P CRF35_AD AF095 CRF36_cpx NYU830 CRF37_cpx NYU926 CRF38_BF UY03_3389 CRF39_BF 03BRRJ103 CRF40_BF 05BRRJ055 CRF41_CD CO6650V1 CRF42_BF luBF_13_05 CRF43_02G J11223 CRF44_BF CH80 CRF45_cpx 04FR.AKU CRF46_BF 01BR087 CRF47_BF P1942 CRF48_01B 07MYKT014 CRF49_cpx N28353 CRF50 CRF51_01B HM021 5 Roche TaqMan 10 Roche 1.0 15 Roche 1.5 ultra-sensitive 19 Any Roche (unspecified) 20 NASBA 21 NASBA ultra-sensitive 29 Any NASBA (unspecified) 31 Chiron b-DNA 1.0 32 Chiron b-DNA 2.0 33 Chiron b-DNA 3.0 39 Any Chiron (unspecified) 40 Abbott ultra-sensitive 41 Abbott LCx 50 Monitor 1.0 51 Monitor 1.0 ultra-sensitive 55 Monitor 1.5 56 Monitor 1.5 ultra-sensitive 65 Cobas 1.5 66 Cobas 1.5 ultra-sensitive 90 Other 99 Unknown BVA Bacterial vaginosis unspecified method BVAC Bacterial vaginosis - clinical BVAG Bacterial vaginosis - gram stain CHLA Chalmydia CMVA CMV anitbodies GONO Gonorrhoe HBV Marker for hepatitis B infection (=HBVAC) - test unknown HBVAC HBV antibody (core) HBVACIGM HBV antibody (core IgM) HBVACIGG HBG antibody (core IgG) HBVAE HBV antibody (envelope) HBVAS HBV antibody (surface) HBVD HBV-dna HBVGE HBV antigen (envelope) HBVGS HBV antigen (surface) HCV Marker for hepatitis C infection - test unknown HCVA HCV antibody HCVG HCV antigen HCVBD HCV b-dna HCVR HCV-rna HDVA Hepatitis delta antibody HIV-1 HIV-1 test HIV-2 HIV-2 test HIVAE HIV antibodies ELISA HIVAWB HIV antibodies Western blot MYCO Mycoplasma P24AG P24 Ag RUB Rubella STR Streptococcus, group B TOXA Toxo antibodies UREP Ureaplasma 1 Roche qualitative (Amplicor) [HCV and HBV] 2 Roche quantitative test for HBV (Cobas Amplicor HBV monitor) 3 Bayer Bdna quantitative [HCV] 4 Bayer Bdna quantitative [HBV] 5 Roche Taqman 9 Other 1 copies/mL 2 IU/mL 3 Geq (millions of genome equivalent) 01 AIDS (ongoing active disease) 01.1 Infection 01.2 Malignancy 02 Infection (other than 01.1) 02.1 Bacterial 02.1.1 Bacterial with sepsis 02.2 Others 02.2.1 Others with sepsis 02.3 Unknown aetiology 02.3.1 Unknown with sepsis 03 Chronic viral hepatitis (progression of/complication to) 03.1 HCV 03.1.1 HCV with cirrhosis 03.1.2 HCV with liver failure 03.2 HBV 03.2.1 HBF with cirrhosis 03.2.2 HBV with liver failure 04 Malignancy (other than 01.2 and 03, 03.1, 03.2) 05 Diabetes Mellitus (complication to) 06 Pancreatitis 07 Lactic acidosis 08 MI or other ischemic heart disease 09 Stroke 10 Gastro-intestinal haemorrhage (if chosen, specify underlying cause) 11 Primary pulmonary hypertension 12 Lung embolus 13 Chronic obstructive lung disease 14 Liver failure (other than 03, 03.1, 03.2) 15 Renal failure 16 Accident or other violent death (not suicide) 17 Suicide 18 Euthenasia 19 Substrance abuse (active) 19.1 Chronic Alcohol abuse 19.2 Chronic intravenous drug-use 19.3 Acute intoxication 20 Haematological disease (other causes) 21 Endocrine disease (other causes) 22 Psychiatric disease (other causes) 23 CNS disease (other causes) 24 Heart or vascular (other causes) 25 Respiratory disease (other causes) 26 Digestive system disease (other causes) 27 Skin and motor system disease (other causes) 28 Urogential disease (other causes) 29 Obstetric complications 30 Congenital disorders 31 Symptoms caused by mitochondrial toxicity (other than 06, 07) 32 Bleeding (haemophilia) 33 Sudden infant death 33.1 Child abuse 90 Other causes 91 Unclassifiable causes 92 Unknown 0 Patient was not infected (mainly for children) 1 Patient lost to follow-up / not known to be dead 2 Patient has not had visit within required amount of time 2.1 Patient did not respond to several invitations 3 Patient moved away 3.1 Patient moved to another country 4 Patient moved and is followed by another centre 4.1 Paediatric patient transferred to adult care 5 Patients decision 5.1 Patients caretaker wanted to discontinue (for children) 6 Consent withdrawn 7 Incarceration/jail 8 Institutionalisation (drug treatment, psychological \u2026etc.) 9 Other A10A Insulin or derivatives hereof A10B Oral antidiabetic agents A14A Anabolic steroids/appetite stimulants B01AC Anti-platelets C-HYP Other anti-hypertensive agents [C02, C03, C04, C07, C08] C09 ACE inhibitors C10 Lipid lowering agents J01AA08 Minocycline (MINOCIN) J01EA01 Trimethoprim (MONOTRIM, NOPIL) J01EC02 Sulfadiazine J01EE Cotrimoxazole - Comb. of sulfonamides and trimethoprim (BACTRIM, EUSAPRIM, NOPIL) J01EE01 Sulfamethoxazole and trimethoprim (Bactrim) J01EE03 Sulfametrole and trimethoprim - Cosoltrime (MADERAN) J01FA09 Clarithromycine (KLACID) J01FA10 Azithomycine (ZITHROMAX) J01FF01 Clindamycine (DALACIN) J01GB06 Amikacine (AMIKINE) J01MA02 Ciprofloxacine (CIPROXINE, CILOXAN) J01MA12 Levofloxacin (TAVANIC) J01MA14 Moxifloxacin J01RA02 Cosoltrime (MADERAN) J02AA01 Amphotericin B (FUNGIZON) J02AB Imidazoles (DAKTARIN, NIZORAL, PEVARYL \u2026) J02AB02 Ketoconazole J02AC01 Fluconazole (DIFLUCAN) J02AC02 Itraconazole (SPORANOX) J02AC03 Voriconazole J02AC04 Posaconazole J02AX01 Flucytosine J04AB02 Rifampin (RIMATICIN) J04AB04 Rifabutin (MYCOBUTIN) J04AC01 Isoniazide (RIMIFON) J04AK01 Pyrazinamide (PYRAZINAMID) J04AK02 Ethambutol (EMB, MYAMBUTOL) J04AM05 RIFATER J04BA01 Clofazimine (LAMPREN) J04BA02 Dapsone J05AB01 Aciclovir (ZIVORAX) J05AB04 Ribavirin J05AB06 Ganciclovir (CYMEVENE) J05AB09 Famciclovir J05AB11 Valaciclovir (VALTEX) J05AB12 Cidofovir (VISTIDE) J05AB15 Valganciclovir J05AD01 Foscarnet (FOSCAVIR) L01AA01 Cyclophosphamide (ENDOXAN) L01AD02 CCNU (LOMUSTINE) L01AX04 Dacabazine (DTIC - Dome) L01BA01 Methotrexate L01CA01 Vinblastin (VELBE) L01CA02 Oncovin (VINCRISTINE) L01CB01 Etoposide (VEPESIDE, EXITOP 100) L01DB01 Doxorubicine, Adriamycine (DOXIL, CAELYX, ADRIBLASTIN) L01DC01 Bleomycine L01XB01 Procarbazine (NATULAN) L03AA02 G-CSF/Filgastrim (NEUPOGEN) L03AB Interferons L03AB-AL2 Peginterferon alfa-2a/alfa-2b (PEGINTRON, PEGASYS) L03AB10 Peginterferon alfa-2b (PEGINTRON) L03AB11 Peginterferon alfa-2a (PEGASYS) L03AC-IL2 Interleukin 2 (PROLEUKIN) P01AX06 Atovaquone (WELLVONE, MEPRONE) P01BA03 Primaquine P01BD01 Pyrimethamine (DARAPRIM) P01BD51 Pyrimethamine/Sulfadoxine (FANSIDAR) P01CX01 Pentamidine aerosol (PENTACARNET) V03AF03 Folinate of calcium (LEUCOVORINE) J01 Antibiotics H02 Corticosteroids G02CA Tocolysis 1 Treatment failure (i.e. virological, immunological, and/or clinical failure 1.1 Virological failure 1.2 Partial virological failure 1.3 Immunological failure - CD4 drop 1.4 Clinical progression 2 Abnormal fat redistribution 3 Concern of cardiovascular disease 3.1 Dyslipidaemia 3.2 Cardiovascular disease 4 Hypersensitivity reaction 5 Toxicity, predominantly from abdomen/G-I tract 5.1 Toxicity - GI tract 5.2 Toxicity - Liver 5.3 Toxicity - Pancreas 6 Toxicity, predominantly from nervous system 7 Toxicity, predominantly from kidneys 8 Toxicity, predominantly from endocrine system 8.1 Diabetes 9 Haematological toxicity (anemia etc.) 10 Hyperlactataemie/lactic acidosis 88 Death 90 Side effects - any of the above but unspecified 90.1 Comorbidity 91 Toxicity, not mentioned above 92 Availability of more effective treatment (not specifically failure or side effect related) 92.1 Simplified treatment available 92.2 Treatment too complex 92.3 Drug interaction 93 Structured Treatment Interruption (STI) 93.1 Structured Treatment Interruption (STI) - at high CD4 94 Patient's wish/decision, not specified above 94.1 Non-compliance 95 Physician's decision, not specified above 96 Pregnancy 97 Study treatment 98 Other causes, not specified above 99 Unknown